Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Continuous Glucose Monitoring (CGM) in an Underserved Population

NCT: NCT07135531 · RECRUITING

NCT IDNCT07135531
StatusRECRUITING
Start Date2026-03-19
Completion2027-07

Brief Summary

The investigators aim is to conduct a randomized clinical trial in an underserved population who are either uninsured or on Medicaid and taking at least one injection of insulin daily. The investigators believe that this study will lead to considerable alleviation of health disparities and provide better care for an underserved population. This will be a pilot study to evaluate the feasibility of such a trial in this population before doing a larger multicenter trial.

Frequently Asked Questions

What is Continuous Glucose Monitoring (CGM) in an Underserved Population?

Continuous Glucose Monitoring (CGM) in an Underserved Population is a clinical trial registered under NCT07135531. Current status: RECRUITING.

What is the status of NCT07135531?

The current status of NCT07135531 (Continuous Glucose Monitoring (CGM) in an Underserved Population) is: RECRUITING.

When did Continuous Glucose Monitoring (CGM) in an Underserved Population start?

Continuous Glucose Monitoring (CGM) in an Underserved Population started on 2026-03-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.